Find More Contacts for Acadia Pharmaceuticals Inc.
Protected Content
CEO
Executive Management
1 email found
View contacts for Acadia Pharmaceuticals Inc. to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@acadia-pharm.com
  • Phone Number (858) 558-2871

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. The

Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.

Lists Featuring This Company

Greater San Diego Area Companies With More Than 100 Employees
1,990 Number of Organizations â€¢ $75B Total Funding Amount â€¢ 1,614 Number of Investors
San Diego Companies With Less Than $1B in Revenue
8,003 Number of Organizations â€¢ $55.8B Total Funding Amount â€¢ 3,785 Number of Investors
National Institute of Neurological Disorders and Stroke Portfolio Companies
38 Number of Organizations â€¢ $2.8B Total Funding Amount â€¢ 241 Number of Investors
California Public Companies With More Than 100 Employees
732 Number of Organizations â€¢ $536.1B Total Funding Amount â€¢ 5,622 Number of Investors

Frequently Asked Questions

Where is Acadia Pharmaceuticals Inc.'s headquarters? Acadia Pharmaceuticals Inc. is located in San Diego, California, United States.Who invested in Acadia Pharmaceuticals Inc.? Acadia Pharmaceuticals Inc. has 18 investors including National Institute of Neurological Disorders and Stroke and New Enterprise Associates.How much funding has Acadia Pharmaceuticals Inc. raised to date? Acadia Pharmaceuticals Inc. has raised .When was the last funding round for Acadia Pharmaceuticals Inc.? Acadia Pharmaceuticals Inc. closed its last funding round on Sep 17, 2019 from a Post-IPO Equity round.Who are Acadia Pharmaceuticals Inc.'s competitors? Alternatives and possible competitors to Acadia Pharmaceuticals Inc. may include Arrowhead PharmaceuticalsEyePoint Pharmaceuticals, and Adamas Pharmaceuticals.